Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study
Aims: To describe pulmonary function 3–6 months following acute COVID-19, to evaluate potential predictors of decreased pulmonary function and to review literature for the effect of COVID-19 on pulmonary function. Materials and methods: A systematic review and cohort study were conducted. Within the...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024039951 |
| _version_ | 1827293963936071680 |
|---|---|
| author | Merel E.B. Cornelissen Asabi Leliveld Nadia Baalbaki Debbie Gach Ivo van der Lee Esther J. Nossent Lizan D. Bloemsma Anke H. Maitland-van der Zee |
| author_facet | Merel E.B. Cornelissen Asabi Leliveld Nadia Baalbaki Debbie Gach Ivo van der Lee Esther J. Nossent Lizan D. Bloemsma Anke H. Maitland-van der Zee |
| author_sort | Merel E.B. Cornelissen |
| collection | DOAJ |
| description | Aims: To describe pulmonary function 3–6 months following acute COVID-19, to evaluate potential predictors of decreased pulmonary function and to review literature for the effect of COVID-19 on pulmonary function. Materials and methods: A systematic review and cohort study were conducted. Within the P4O2 COVID-19 cohort, 95 patients aged 40–65 years were recruited from outpatient post-COVID-19 clinics in five Dutch hospitals between May 2021–September 2022. At 3–6 months post COVID-19, medical records data and biological samples were collected and questionnaires were administered. In addition, pulmonary function tests (PFTs), including spirometry and transfer factor, were performed. To identify factors associated with PFTs, linear regression analyses were conducted, adjusted for covariates. Results: In PFTs (n = 90), mean ± SD % of predicted was 89.7 ± 18.2 for forced vital capacity (FVC) and 79.8 ± 20.0 for transfer factor for carbon monoxide (DLCO). FVC was <LLN in 24.4%, and DLCO was <LLN in 40.2% of patients. Univariable analyses showed that higher age, severe acute infection, pulmonary embolism during acute infection, and male sex were associated with lower DLCO. Multivariable analysis showed that age (adjusted difference [95%CI] = -0.07 [-0.13,-0.02] per one year increase) and severe acute infection (−0.80 [-1.54,-0.05]) were independently associated with a decreased DLCO. In literature we found days on oxygen supplementation, female sex, longer length of hospital stay, obesity and higher age to be associated with lower DLCO after COVID-19. Conclusion: A low DLCO 3–6 months following acute COVID-19 was observed more often than a low FVC, both in the P4O2 COVID-19 study and the literature review. |
| first_indexed | 2024-04-24T13:47:50Z |
| format | Article |
| id | doaj.art-0ae1818b65264791a50c48fb3fe9636a |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-04-24T13:47:50Z |
| publishDate | 2024-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-0ae1818b65264791a50c48fb3fe9636a2024-04-04T05:06:28ZengElsevierHeliyon2405-84402024-03-01106e27964Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort studyMerel E.B. Cornelissen0Asabi Leliveld1Nadia Baalbaki2Debbie Gach3Ivo van der Lee4Esther J. Nossent5Lizan D. Bloemsma6Anke H. Maitland-van der Zee7Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, 1105, AZ Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Amsterdam Public Health, Amsterdam, the Netherlands; Corresponding author. Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, 1105, AZ Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Amsterdam Public Health, Amsterdam, the NetherlandsDepartment of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, 1105, AZ Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Amsterdam Public Health, Amsterdam, the NetherlandsDepartment of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, the Netherlands; School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, the NetherlandsDepartment of Pulmonology, Spaarne Hospital, the NetherlandsDepartment of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, 1105, AZ Amsterdam, the NetherlandsDepartment of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, 1105, AZ Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Amsterdam Public Health, Amsterdam, the NetherlandsDepartment of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, 1105, AZ Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Amsterdam Public Health, Amsterdam, the NetherlandsAims: To describe pulmonary function 3–6 months following acute COVID-19, to evaluate potential predictors of decreased pulmonary function and to review literature for the effect of COVID-19 on pulmonary function. Materials and methods: A systematic review and cohort study were conducted. Within the P4O2 COVID-19 cohort, 95 patients aged 40–65 years were recruited from outpatient post-COVID-19 clinics in five Dutch hospitals between May 2021–September 2022. At 3–6 months post COVID-19, medical records data and biological samples were collected and questionnaires were administered. In addition, pulmonary function tests (PFTs), including spirometry and transfer factor, were performed. To identify factors associated with PFTs, linear regression analyses were conducted, adjusted for covariates. Results: In PFTs (n = 90), mean ± SD % of predicted was 89.7 ± 18.2 for forced vital capacity (FVC) and 79.8 ± 20.0 for transfer factor for carbon monoxide (DLCO). FVC was <LLN in 24.4%, and DLCO was <LLN in 40.2% of patients. Univariable analyses showed that higher age, severe acute infection, pulmonary embolism during acute infection, and male sex were associated with lower DLCO. Multivariable analysis showed that age (adjusted difference [95%CI] = -0.07 [-0.13,-0.02] per one year increase) and severe acute infection (−0.80 [-1.54,-0.05]) were independently associated with a decreased DLCO. In literature we found days on oxygen supplementation, female sex, longer length of hospital stay, obesity and higher age to be associated with lower DLCO after COVID-19. Conclusion: A low DLCO 3–6 months following acute COVID-19 was observed more often than a low FVC, both in the P4O2 COVID-19 study and the literature review.http://www.sciencedirect.com/science/article/pii/S2405844024039951Post COVID-19Pulmonary functionTransfer factor for carbon monoxideLong COVID |
| spellingShingle | Merel E.B. Cornelissen Asabi Leliveld Nadia Baalbaki Debbie Gach Ivo van der Lee Esther J. Nossent Lizan D. Bloemsma Anke H. Maitland-van der Zee Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study Heliyon Post COVID-19 Pulmonary function Transfer factor for carbon monoxide Long COVID |
| title | Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study |
| title_full | Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study |
| title_fullStr | Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study |
| title_full_unstemmed | Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study |
| title_short | Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study |
| title_sort | pulmonary function 3 6 months after acute covid 19 a systematic review and multicentre cohort study |
| topic | Post COVID-19 Pulmonary function Transfer factor for carbon monoxide Long COVID |
| url | http://www.sciencedirect.com/science/article/pii/S2405844024039951 |
| work_keys_str_mv | AT merelebcornelissen pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy AT asabileliveld pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy AT nadiabaalbaki pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy AT debbiegach pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy AT ivovanderlee pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy AT estherjnossent pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy AT lizandbloemsma pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy AT ankehmaitlandvanderzee pulmonaryfunction36monthsafteracutecovid19asystematicreviewandmulticentrecohortstudy |